Sedation is one of the details of ICU care which seems unimportant… until it's not. Over the past decade we've seen a burgeoning repertoire of agents used for sedation and agitated delirium. Unfortunately, the number of medications has out-stripped available Level-I evidence regarding how exactly to use them. This chapter attempts to create a framework for the selection and use of various agents. Looming drug shortages due to COVID-19 may force us to push the envelope, by using different agents in ways which we haven't previously.
-
The IBCC chapter is located 👉 here.
- The podcast & comments are below.
Follow us on iTunes
Josh is the creator of PulmCrit.org. He is an associate professor of Pulmonary and Critical Care Medicine at the University of Vermont.
Latest posts by Josh Farkas (see all)
- PulmCrit – Want to help stop COVID?Be quiet. - December 1, 2020
- PulmCrit – I’m so confused about bamlanivimab - November 30, 2020
- PulmCrit – Oscar awards for the best COVID prognostic models - November 28, 2020
Incredibly helpful chapter as always. I have learned a tremendous amount from your posts and have been able to apply the knowledge gained to numerous cases in our dept. Thank you for what you do.
fantastic work! may want to add status epilepticus to midaz infusions indications
[…] ,Sedation is one of the details of ICU care which seems unimportant… until it’s not. Over the past decade we’ve seen a burgeoning repertoire of agents used for sedation and agitated delirium. Unfortunately, the number of medications has out-stripped available Level-I evidence regarding how exactly to use them. This chapter attempts to create a framework EMCrit Project by Josh Farkas.,Read More […]
Helpful as always! Excellent
we use form time to time sedation with inhalational anaesthetics in the intensive care unit with the AnaConDa® device. somestudies have shown superiority of volatile anaesthetic agents over intravenous drugs for ICU sedation. it give you shorter time on ventilator and could be discharged from icu faster. it may help in status asmaticus, and ARDS ( RCT is comming). and the cost is low. here in EU is used allot in Germany and france.and we here in denmark is starting.